These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4202457

  • 1. Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.
    Flannery GR, Chalmers PJ, Rolland JM, Nairn RC.
    Br J Cancer; 1973 Oct; 28(4):293-8. PubMed ID: 4202457
    [Abstract] [Full Text] [Related]

  • 2. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Flannery GR, Chalmers PJ, Rolland JM, Nairn RC.
    Br J Cancer; 1973 Aug; 28(2):118-22. PubMed ID: 4542343
    [Abstract] [Full Text] [Related]

  • 3. Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.
    Chalmers PJ, Matthews N, Nairn RC.
    Br J Cancer; 1976 Dec; 34(6):645-50. PubMed ID: 1087566
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
    Matthews N, Chalmers PJ, Flannery GR, Nairn RC.
    Br J Cancer; 1976 Mar; 33(3):279-89. PubMed ID: 773397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.
    Basham C, Currie GA.
    Br J Cancer; 1974 Mar; 29(3):189-98. PubMed ID: 4830142
    [Abstract] [Full Text] [Related]

  • 7. Analysis of cell membrane antigens using radioiodinated, purified antibodies. II. A factor in the serum of hamsters bearing SV 40 -induced tumors which reacts with antibodies to SV 40 -transformed cell membranes.
    Kedar E, Spira G, Sulitzeanu D.
    Isr J Med Sci; 1973 Mar; 9(3):277-83. PubMed ID: 4350975
    [No Abstract] [Full Text] [Related]

  • 8. Blocking of the lymphocyte antigen receptor site with anti-immunoglobulin sera in vitro.
    Warner NL, Byrt P, Ada GL.
    Nature; 1970 Jun 06; 226(5249):942-3. PubMed ID: 4192295
    [No Abstract] [Full Text] [Related]

  • 9. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR, Baldwin RW.
    Int J Cancer; 1977 Aug 15; 20(2):284-91. PubMed ID: 197028
    [Abstract] [Full Text] [Related]

  • 10. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes.
    Donovan G, Dumitrescu R, Popp I, Maltezeanu G.
    Neoplasma; 1971 Aug 15; 18(3):241-9. PubMed ID: 5093945
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Baldwin RW, Price MR, Robins RA.
    Nat New Biol; 1972 Aug 09; 238(84):185-6. PubMed ID: 4340574
    [No Abstract] [Full Text] [Related]

  • 13. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
    Ptak W.
    Allerg Immunol (Leipz); 1973 Aug 09; 19(2-4):290-6. PubMed ID: 4375939
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM, Gurin JL.
    Immunology; 1989 Jan 09; 66(1):26-31. PubMed ID: 15493258
    [Abstract] [Full Text] [Related]

  • 15. [Increase in the immunostimulation properties of inactivated Brucella abortus B 19 by simultaneous use of a specific immune serum].
    Toujas L, Dazord L, Guefi J.
    C R Acad Hebd Seances Acad Sci D; 1973 Jan 15; 276(3):433-6. PubMed ID: 4197497
    [No Abstract] [Full Text] [Related]

  • 16. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG, Robins RA, Baldwin RW.
    Int J Cancer; 1975 Apr 15; 15(4):640-50. PubMed ID: 166943
    [Abstract] [Full Text] [Related]

  • 17. Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.
    Currie GA, Gage JO.
    Br J Cancer; 1973 Aug 15; 28(2):136-46. PubMed ID: 4730177
    [Abstract] [Full Text] [Related]

  • 18. Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes.
    Mond JJ, Takahashi T, Thorbecke GJ.
    J Exp Med; 1972 Oct 01; 136(4):715-21. PubMed ID: 4626849
    [Abstract] [Full Text] [Related]

  • 19. Immune response of mice in immunotherapy of tumors with syngeneic antitumor serum plus lipopolysaccharide.
    Saito M, Yamazaki M, Mizuno D.
    Gan; 1978 Jun 01; 69(3):331-7. PubMed ID: 352784
    [Abstract] [Full Text] [Related]

  • 20. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
    Stolfi RL, Fugmann RA, Stolfi LM, Martin DS.
    J Immunol; 1975 Jun 01; 114(6):1824-30. PubMed ID: 1127230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.